Insider Trading & Ownership - RA CAPITAL MANAGEMENT L.P.

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for RA CAPITAL MANAGEMENT L.P.
Goto Prev, 0, 1, 2, 3, ...5, 6, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-06-27
Purchase
2024-07-01
9:29 pm
Eliem Therapeutics Inc. ELYM RA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund L.P.
RA Capital Nexus Fund II L.P.
RA Capital Nexus Fund III L.P.
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
13,008,546 $3.84 $49,952,817 5,417,638
(Indirect)
View
2024-06-17
Purchase
2024-06-20
5:56 pm
Aerovate Therapeutics Inc. AVTE RA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund L.P.
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
928,110 $1.67 $1,549,944 9,192,092
(Indirect)
View
2024-04-02
Purchase
2024-04-04
4:15 pm
Boundless Bio Inc. BOLD RA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund II L.P.
Kolchinsky Peter
Shah Rajeev M.
10% Owner
312,500 $16 $5,000,000 295,844
(Indirect)
View
2024-03-27
Purchase
2024-03-29
5:38 pm
Nkarta Inc. NKTX RA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund L.P.
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
3,000,000 $10 $30,000,000 13,805,160
(Indirect)
View
2024-03-25
Purchase
2024-03-27
7:37 pm
ARS Pharmaceuticals Inc. SPRY RA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund II L.P.
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
1,401,299 $9.4836 $13,289,410 10,860,977
(Indirect)
View
2024-03-21
Purchase
2024-03-25
8:48 pm
LENZ Therapeutics Inc. LENZ RA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund II L.P.
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
998,009 $15.03 $15,000,075 792,288
(Indirect)
View
2024-03-04
Purchase
2024-03-06
5:40 pm
89bio Inc. ETNB RA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund L.P.
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
1,350,000 $15.35 $20,722,500 12,766,948
(Indirect)
View
2024-02-09
Purchase
2024-02-13
4:33 pm
PepGen Inc. PEPG RA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund II L.P.
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
2,557,593 $10.64 $27,212,790 10,689,545
(Indirect)
View
2023-12-11
Purchase(A)
2024-01-17
7:06 pm
Wave Life Sciences Ltd. WVE RA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
1,000,000 $5 $5,000,000 18,202,009
(Indirect)
View
2024-01-11
Purchase
2024-01-12
5:01 pm
Solid Biosciences Inc. SLDB RA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
Kolchinsky Peter
Shah Rajeev M.
RA Capital Nexus Fund L.P.
Director
10% Owner
904,160 $5.53 $5,000,005 4,301,877
(Indirect)
View
2023-12-11
Purchase
2023-12-13
4:33 pm
Wave Life Sciences Ltd. WVE RA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
1,000,000 $5 $5,000,000 19,202,009
(Indirect)
View
2023-09-21
Purchase
2023-09-25
4:30 pm
ARS Pharmaceuticals Inc. SPRY RA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund II L.P.
Kolchinsky Peter
Shah Rajeev M.
Director
2,700,000 $3.0309 $8,183,526 9,459,678
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-07-18
Option Award
2024-07-22
5:11 pm
N/A
N/A
Cidara Therapeutics Inc. CDTX RA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
Kolchinsky Peter
Shah Rajeev M.
Director
100,000 $1000 893,036
(Indirect)
View
2024-07-19
Conversion
2024-07-22
5:11 pm
N/A
N/A
Cidara Therapeutics Inc. CDTX RA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
Kolchinsky Peter
Shah Rajeev M.
Director
713,124 $0 893,036
(Indirect)
View
2024-07-18
Option Award(A)
2024-07-22
5:09 pm
N/A
2034-07-17
Cidara Therapeutics Inc. CDTX RA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
Kolchinsky Peter
Shah Rajeev M.
Director
2,125 $0 2,125
(Indirect)
View
2024-07-18
Option Award
2024-07-19
5:16 pm
N/A
2034-07-17
Cidara Therapeutics Inc. CDTX RA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
Kolchinsky Peter
Shah Rajeev M.
Director
2,125 $0 2,125
(Indirect)
View

Ownership
2024-07-18
8:08 pm
N/A
N/A
Artiva Biotherapeutics Inc. ARTV RA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund L.P.
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
0 $0 1,058,282
(Indirect)
View
2024-06-27
Option Award
2024-07-01
9:29 pm
N/A
N/A
Eliem Therapeutics Inc. ELYM RA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund L.P.
RA Capital Nexus Fund II L.P.
RA Capital Nexus Fund III L.P.
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
5,259,872 $0 5,417,638
(Indirect)
View
2024-06-26
Option Award
2024-06-28
6:14 pm
N/A
2034-06-25
Eliem Therapeutics Inc. ELYM RA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund L.P.
RA Capital Nexus Fund II L.P.
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
10,000 $0 10,000
(Indirect)
View
2024-06-26
Option Award
2024-06-28
4:35 pm
N/A
2034-06-25
Janux Therapeutics Inc. JANX RA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund II L.P.
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
10,850 $0 9,176,502
(Indirect)
View
2024-06-20
Option Award
2024-06-24
5:36 pm
N/A
2034-06-19
Acrivon Therapeutics Inc. ACRV RA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund II L.P.
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
20,275 $0 20,275
(Indirect)
View
2024-06-20
Option Award
2024-06-24
5:13 pm
N/A
2034-06-19
ARS Pharmaceuticals Inc. SPRY RA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund II L.P.
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
40,000 $0 40,000
(Indirect)
View
2024-06-20
Option Award
2024-06-21
4:14 pm
N/A
2034-06-19
PepGen Inc. PEPG RA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund II L.P.
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
13,000 $0 13,000
(Indirect)
View
2024-06-13
Option Award
2024-06-14
4:18 pm
N/A
2034-06-12
Nkarta Inc. NKTX RA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund L.P.
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
22,500 $0 22,500
(Indirect)
View
2024-06-10
Option Award
2024-06-10
5:26 pm
N/A
2034-06-09
Acumen Pharmaceuticals Inc. ABOS RA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund II L.P.
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
25,000 $0 25,000
(Indirect)
View
2024-06-05
Option Award
2024-06-07
8:29 pm
N/A
2034-06-04
Aerovate Therapeutics Inc. AVTE RA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund L.P.
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
12,500 $0 12,500
(Indirect)
View
2024-05-29
Option Award
2024-05-31
6:26 pm
N/A
2034-05-28
Tyra Biosciences Inc. TYRA RA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund L.P.
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
18,600 $0 18,600
(Indirect)
View
2024-05-22
Option Award
2024-05-28
6:51 pm
N/A
2034-05-22
Mineralys Therapeutics Inc. MLYS RA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund III L.P.
Kolchinsky Peter
Shah Rajeev M.
Director
22,000 $0 22,000
(Indirect)
View
2024-05-23
Option Award
2024-05-28
4:10 pm
N/A
2034-05-22
Vor Biopharma Inc. VOR RA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund L.P.
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
30,000 $0 30,000
(Indirect)
View
2024-05-24
Option Award
2024-05-24
7:56 pm
N/A
2034-05-23
Werewolf Therapeutics Inc. HOWL RA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund II L.P.
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
17,500 $0 17,500
(Indirect)
View
2024-05-12
Other
2024-05-14
9:06 pm
N/A
N/A
iTeos Therapeutics Inc. ITOS RA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
Kolchinsky Peter
Shah Rajeev M.
Former 10% Owner
900,000 $0 16,745,829
(Indirect)
View
2024-04-26
Option Award
2024-04-30
4:37 pm
N/A
2034-04-25
Cidara Therapeutics Inc. CDTX RA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
Kolchinsky Peter
Shah Rajeev M.
Director
4,250 $0 4,250
(Indirect)
View
2023-02-09
Option Award
2024-04-15
4:15 pm
N/A
2033-02-09
89bio Inc. ETNB RA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund L.P.
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
72,550 $0 14,247,948
(Indirect)
View
2024-04-11
Exercise
2024-04-15
4:15 pm
2022-07-01
2024-07-01
89bio Inc. ETNB RA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund L.P.
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
2,816,900 $0 14,247,948
(Indirect)
View
2024-04-11
Exercise
2024-04-15
4:15 pm
N/A
N/A
89bio Inc. ETNB RA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund L.P.
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
1,408,450 $5.325 14,247,948
(Indirect)
View
2024-04-11
Option Award
2024-04-15
4:15 pm
N/A
N/A
Acrivon Therapeutics Inc. ACRV RA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund II L.P.
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
3,530,000 $8.5 8,340,508
(Indirect)
View
2024-04-02
Conversion
2024-04-04
4:15 pm
N/A
N/A
Boundless Bio Inc. BOLD RA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund II L.P.
Kolchinsky Peter
Shah Rajeev M.
10% Owner
38,296,702 $0 295,844
(Indirect)
View

Ownership
2024-03-27
8:16 pm
N/A
N/A
Boundless Bio Inc. BOLD RA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund II L.P.
Kolchinsky Peter
Shah Rajeev M.
10% Owner
0 $0 1,868,131
(Indirect)
View
2024-03-21
Option Award
2024-03-25
8:48 pm
2024-03-21
2027-10-30
LENZ Therapeutics Inc. LENZ RA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund II L.P.
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
3,343,318 $0 792,288
(Indirect)
View
2024-02-19
Equity Swap
2024-02-20
8:07 pm
N/A
N/A
Icosavax Inc. ICVX RA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund II L.P.
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
5,969,108 $0 0
(Indirect)
View
2024-02-12
Option Award
2024-02-14
7:49 pm
N/A
N/A
Mineralys Therapeutics Inc. MLYS RA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund III L.P.
Kolchinsky Peter
Shah Rajeev M.
Director
549,755 $13.5 5,400,739
(Indirect)
View
2024-02-12
Option Award
2024-02-14
7:49 pm
N/A
N/A
Mineralys Therapeutics Inc. MLYS RA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund III L.P.
Kolchinsky Peter
Shah Rajeev M.
Director
1,672,508 $13.5 5,400,739
(Indirect)
View
2024-02-06
Option Award
2024-02-08
5:16 pm
N/A
N/A
Tyra Biosciences Inc. TYRA RA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund L.P.
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
3,180,155 $13.01 11,955,066
(Indirect)
View
2024-02-06
Option Award
2024-02-08
5:16 pm
N/A
N/A
Tyra Biosciences Inc. TYRA RA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund L.P.
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
1,538,457 $13.01 11,955,066
(Indirect)
View
(A) Indicate amendment filing.
Goto Prev, 0, 1, 2, 3, ...5, 6, Next